Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 3,411 | $25K |
| Open-market sale | 16 | 1,333,677 | $7.95M |
| Option exercise | 22 | 1,197,476 | |
| Tax withholding / forfeiture | 5 | 22,481 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
67 Form 4 filings on record, the earliest from Dec 30, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 185,000 | $7.44 | $1.38M | ||
| Nancy H. Agee - Director | Open-market purchase | Common Stock | 3,411 | $7.23 | $25K | |
| Option exercise | Common Stock | 5,208 | - | - | ||
| Tax withholding / forfeiture | Common Stock | 2,488 | $7.20 | $18K | ||
| Option exercise | Restricted Stock Units | 5,208 | $0.00 | - | ||
| Harry Thomasian Jr. - Officer | Option exercise | Common Stock | 7,291 | - | - | |
| Harry Thomasian Jr. - Officer | Tax withholding / forfeiture | Common Stock | 3,577 | $7.20 | $26K | |
| Harry Thomasian Jr. - Officer | Option exercise | Restricted Stock Units | 7,291 | $0.00 | - | |
| Option exercise | Common Stock | 34,658 | $2.33 | $81K | ||
| Open-market sale | Common Stock | 34,658 | $7.50 | $260K | ||
| Option exercise | Common Stock | 7,500 | - | - | ||
| Tax withholding / forfeiture | Common Stock | 3,647 | $7.20 | $26K | ||
| Option exercise | Common Stock | 15,342 | $2.33 | $36K | ||
| Open-market sale | Common Stock | 15,342 | $7.50 | $115K | ||
| Option exercise | Option to Purchase Common Stock (Right to Buy) | 34,658 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 7,500 | $0.00 | - | ||
| Option exercise | Option to Purchase Common Stock (Right to Buy) | 15,342 | $0.00 | - | ||
| Phil Tennant - Officer | Option exercise | Common Stock | 5,208 | - | - | |
| Phil Tennant - Officer | Tax withholding / forfeiture | Common Stock | 2,585 | $7.20 | $19K | |
| Phil Tennant - Officer | Option exercise | Common Stock | 79,166 | $1.61 | $127K | |
| Phil Tennant - Officer | Open-market sale | Common Stock | 79,166 | $7.50 | $594K | |
| Phil Tennant - Officer | Option exercise | Restricted Stock Units | 5,208 | $0.00 | - | |
| Phil Tennant - Officer | Option exercise | Option to Purchase Common Stock (Right to Buy) | 79,166 | $0.00 | - | |
| Option exercise | Common Stock | 20,833 | - | - | ||
| Tax withholding / forfeiture | Common Stock | 10,184 | $7.20 | $73K | ||
| Option exercise | Restricted Stock Units | 20,833 | $0.00 | - | ||
| Open-market sale | Common Stock | 32,739 | $6.86 | $225K | ||
| Option exercise | Common Stock | 33,772 | $2.33 | $79K | ||
| Open-market sale | Common Stock | 33,772 | $6.50 | $220K | ||
| Option exercise | Option to Purchase Common Stock (Right to Buy) | 33,772 | $0.00 | - | ||
| Harry Thomasian Jr. - Officer | Open-market sale | Common Stock | 100,000 | $6.06 | $606K | |
| Harry Thomasian Jr. - Officer | Open-market sale | Common Stock | 28,571 | $5.78 | $165K | |
| Harry Thomasian Jr. - Officer | Open-market sale | Common Stock | 171,429 | $5.53 | $948K | |
| Option exercise | Common Stock | 42,924 | $2.33 | $100K | ||
| Open-market sale | Common Stock | 42,924 | $5.85 | $251K | ||
| Option exercise | Option to Purchase Common Stock (Right to Buy) | 42,924 | $0.00 | - | ||
| Option exercise | Common Stock | 346,836 | $2.33 | $808K | ||
| Open-market sale | Common Stock | 346,836 | $5.89 | $2.04M | ||
| Option exercise | Option to Purchase Common Stock (Right to Buy) | 346,836 | $0.00 | - | ||
| Harry Thomasian Jr. - Officer | Open-market sale | Common Stock | 41,884 | $4.36 | $183K | |
| Phil Tennant - Officer | Open-market sale | Common Stock | 30,272 | $4.36 | $132K | |
| Open-market sale | Common Stock | 42,703 | $4.36 | $186K | ||
| Open-market sale | Common Stock | 29,131 | $4.36 | $127K | ||
| Open-market sale | Common Stock | 119,250 | $4.36 | $520K | ||
| Harry Thomasian Jr. - Officer | Option exercise | Common Stock | 87,500 | - | - | |
| Harry Thomasian Jr. - Officer | Option exercise | Restricted Stock Units | 87,500 | $0.00 | - | |
| Phil Tennant - Officer | Option exercise | Common Stock | 62,500 | - | - | |
| Phil Tennant - Officer | Option exercise | Restricted Stock Units | 62,500 | $0.00 | - | |
| Option exercise | Common Stock | 90,000 | - | - | ||
| Option exercise | Restricted Stock Units | 90,000 | $0.00 | - | ||
| Option exercise | Common Stock | 250,000 | - | - | ||
| Option exercise | Restricted Stock Units | 250,000 | $0.00 | - | ||
| Option exercise | Common Stock | 62,500 | - | - | ||
| Option exercise | Restricted Stock Units | 62,500 | $0.00 | - | ||
| Grant or award | Option to Purchase Common Stock (Right to Buy) | 358,000 | $0.00 | - | ||
| Grant or award | Restricted Stock Units | 107,000 | $0.00 | - | ||
| Grant or award | Option to Purchase Common Stock (Right to Buy) | 1,366,000 | $0.00 | - | ||
| Grant or award | Restricted Stock Units | 410,000 | $0.00 | - | ||
| Grant or award | Option to Purchase Common Stock (Right to Buy) | 395,000 | $0.00 | - | ||
| Grant or award | Restricted Stock Units | 118,000 | $0.00 | - | ||
| Phil Tennant - Officer | Grant or award | Option to Purchase Common Stock (Right to Buy) | 385,000 | $0.00 | - | |
| Phil Tennant - Officer | Grant or award | Restricted Stock Units | 115,000 | $0.00 | - | |
| Harry Thomasian Jr. - Officer | Grant or award | Option to Purchase Common Stock (Right to Buy) | 399,000 | $0.00 | - | |
| Harry Thomasian Jr. - Officer | Grant or award | Restricted Stock Units | 120,000 | $0.00 | - | |
| Open-market sale | Common Stock | 23,789 | $3.30 | $79K | ||
| Open-market sale | Common Stock | 2,334,420 | $3.30 | $7.70M | ||
| Open-market sale | Common Stock | 50,797 | $3.30 | $168K | ||
| Open-market sale | Common Stock | 1,108,998 | $3.30 | $3.66M | ||
| Open-market sale | Common Stock | 50,797 | $3.30 | $168K | ||
| Open-market sale | Common Stock | 370,847 | $3.30 | $1.22M | ||
| Open-market sale | Common Stock | 152,063 | $3.30 | $502K | ||
| Open-market sale | Common Stock | 426,199 | $3.30 | $1.41M | ||
| Open-market sale | Common Stock | 168,794 | $3.30 | $557K | ||
| Open-market sale | Common Stock | 47,101 | $3.30 | $155K | ||
| Open-market sale | Common Stock | 38,976 | $3.30 | $129K | ||
| Harry Thomasian Jr. - Officer | Option exercise | Common Stock | 40,293 | - | - | |
| Harry Thomasian Jr. - Officer | Grant or award | Restricted Stock Units | 40,293 | $0.00 | - | |
| Harry Thomasian Jr. - Officer | Option exercise | Restricted Stock Units | 40,293 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Jeffrey Kindler | Director | 185,000 | $1.37M | View on EDGAR | |
| Tennant Phil | Officer | 79,166 | $594K | View on EDGAR | |
| Shah Rutul R | Officer | 15,342 | $115K | View on EDGAR |
PRECIGEN, INC. (PGEN) had 18 insider filings in the last 90 days, with the most recent on 2026-08-29. The full record for PGEN runs to 67 Form 4 filings, the earliest from 2024-12-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
1 insider purchase of PGEN was filed in the last 90 days, totaling $25K.
16 insider sales of PGEN were filed in the last 90 days, totaling $7.95M.
This page tracks PGEN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PGEN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.